{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 4553 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "10018930", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "1", "seriousnesshospitalization": "1", "receivedateformat": "102", "receivedate": "20140318", "receiptdateformat": "102", "receiptdate": "20140318", "fulfillexpeditecriteria": "1", "companynumb": "US-GLAXOSMITHKLINE-A1064326A", "duplicate": "1", "reportduplicate": { "duplicatesource": "GLAXOSMITHKLINE", "duplicatenumb": "US-GLAXOSMITHKLINE-A1064326A" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "57", "patientonsetageunit": "801", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Loss of consciousness", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Blood glucose increased", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Blood glucose decreased", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Hypoglycaemia", "reactionoutcome": "6" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Blood glucose fluctuation", "reactionoutcome": "6" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "ADVAIR", "drugbatchnumb": "3ZP1794", "drugauthorizationnumb": "021077", "drugstructuredosagenumb": "1", "drugstructuredosageunit": "032", "drugseparatedosagenumb": "2", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "1PUFF TWICE PER DAY", "drugdosageform": "Multi dose powder inhaler", "drugadministrationroute": "055", "drugindication": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "drugstartdateformat": "602", "drugstartdate": "2002", "actiondrug": "4", "openfda": { "application_number": [ "NDA021077" ], "brand_name": [ "ADVAIR DISKUS" ], "generic_name": [ "FLUTICASONE PROPIONATE AND SALMETEROL" ], "manufacturer_name": [ "GlaxoSmithKline LLC" ], "product_ndc": [ "0173-0695", "0173-0696", "0173-0697" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "RESPIRATORY (INHALATION)" ], "substance_name": [ "SALMETEROL XINAFOATE", "FLUTICASONE PROPIONATE" ], "rxcui": [ "896161", "896165", "896184", "896185", "896186", "896190", "896209", "896212", "896218", "896222", "896228", "896229" ], "spl_id": [ "0add9a7a-38ae-489a-9635-7b85c20ba985" ], "spl_set_id": [ "4eeb5f6a-593f-4a9e-9692-adefa2caf8fc" ], "package_ndc": [ "0173-0695-00", "0173-0695-04", "0173-0696-00", "0173-0696-04", "0173-0697-00", "0173-0697-04" ], "unii": [ "O2GMZ0LF5W", "6EW8Q962A5" ] } }, { "drugcharacterization": "2", "medicinalproduct": "HCTZ" }, { "drugcharacterization": "2", "medicinalproduct": "PAXIL" }, { "drugcharacterization": "2", "medicinalproduct": "THEOPHYLLINE", "openfda": { "application_number": [ "ANDA090430", "ANDA218063", "ANDA040560", "ANDA090355", "ANDA212184", "ANDA091156", "ANDA218401", "ANDA216961", "ANDA089763", "ANDA214950", "ANDA217422", "ANDA216300", "ANDA091586", "ANDA215312", "ANDA214806", "ANDA081236", "ANDA206344" ], "brand_name": [ "THEOPHYLLINE", "THEOPHYLLINE (ANHYDROUS)" ], "generic_name": [ "THEOPHYLLINE", "THEOPHYLLINE ANHYDROUS" ], "manufacturer_name": [ "Alembic Pharmaceuticals Limited", "Zydus Lifesciences Limited", "Westminster Pharmaceuticals, LLC", "Glenmark Pharmaceuticals Inc., USA", "Viona Pharmaceuticals Inc", "Chartwell RX, LLC", "Ajanta Pharma USA Inc.", "Teva Pharmaceuticals, Inc.", "Alembic Pharmaceuticals Inc.", "Chartwell Governmental & Specialty RX, LLC.", "Leading Pharma, LLC", "Camber Pharmaceuticals, Inc.", "Bionpharma Inc.,", "Cranbury Pharmaceuticals, LLC", "Strides Pharma Science Limited", "Harman Finochem Limited", "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.", "PAI Holdings, LLC dba PAI Pharma" ], "product_ndc": [ "46708-025", "46708-026", "70771-1782", "70771-1783", "69367-414", "69367-415", "68462-356", "68462-380", "72578-173", "72578-174", "68462-721", "68462-722", "62135-556", "27241-272", "27241-273", "0480-3309", "0480-3310", "62332-025", "62332-026", "68999-556", "62135-457", "69315-226", "69315-227", "31722-077", "31722-078", "69452-267", "27808-033", "64380-243", "64380-244", "82638-105", "82638-106", "23155-741", "23155-742", "0121-0820", "0121-4820" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "THEOPHYLLINE ANHYDROUS", "THEOPHYLLINE" ], "rxcui": [ "314241", "317769", "313291", "348472", "313306" ], "spl_id": [ "0d340b17-907e-4c38-bbd6-c4740495a55a", "86fdabb8-c881-4695-8127-59b26998e365", "46766222-63b4-478f-aa8b-a23b20476317", "7c8e32e3-ca36-4ad2-971b-446c12a81992", "1e5a0f45-86aa-498a-9cc3-9f7acc210ed6", "588a56f6-ac5a-415e-99ac-fdb836e0202f", "4a2adbbe-acaa-a2bf-e063-6294a90a44c3", "fbec14fb-bd76-48e7-b61f-b19cd1a3ea2f", "7d1746e6-4ce7-4a14-a2f8-c95bc8941b3c", "d9cbb2b7-6524-4587-9111-e3abfd2e888b", "43905546-0c51-ab49-e063-6294a90a4a31", "459f1504-8f55-630b-e063-6294a90a88d6", "a7dacdee-6f6b-4b85-b051-7779258a6971", "05c7eb1d-0b79-ee46-e063-6294a90abfe4", "07895277-4273-508f-e063-6394a90a40ea", "723b1708-84c4-4a42-99bb-475c77bed2ef", "8eff2537-a9cd-494d-abfc-6e8248abde83", "171269d1-329b-8551-e063-6294a90aedd7", "c8abc0eb-6bb6-4f7b-a7bf-793cf90c5ead", "895f63e5-665b-4227-8e44-6971ba5ce294" ], "spl_set_id": [ "31f3c720-1597-4d43-9296-33017b90b15f", "7339f98d-b996-4e20-a7a7-315fd2a9fa4d", "04f1d1da-ce61-45b3-acf4-903cc81d16da", "56fc2167-ceb6-4e3e-8ff7-5e400dfbd533", "abdfb9b9-9402-4761-9347-8eb1c4d86242", "48330a8e-be08-4d38-b8b1-d30fbd5a35de", "1b685384-5d96-46fa-b93b-e96538a2cfe7", "7a422c32-bbdf-4297-84f4-9c438c904b0c", "25eabefa-518b-4030-9b72-01ac8b3deba9", "77e849b8-900b-4f0d-ac5c-1391abcd5721", "e2716dac-8b23-4e06-bc3e-4dd76b7c813e", "9591d4db-2b88-4f0f-b61e-64ba67626e3d", "ac490ebf-24e1-47c4-a932-ad4dcafe7aad", "bf320619-c53b-49a7-97b5-cd0c075a9f75", "63517422-45a0-4e78-8505-eca054068ee9", "78a99bfe-6ebe-4ace-80b0-ee019921435e", "b7a90ccf-9c32-40cc-9008-7e55b3da4dfd", "098db8bb-fa9a-4577-b7d9-86caaefc168a", "701fbf9c-e06b-46f4-863b-981acf3021aa", "32b9780f-c46f-4e0f-9641-2cab60600e6e" ], "package_ndc": [ "46708-025-30", "46708-025-31", "46708-025-71", "46708-025-91", "46708-026-30", "46708-026-31", "46708-026-71", "70771-1782-1", "70771-1783-1", "69367-414-01", "69367-415-01", "68462-380-01", "68462-380-05", "68462-356-01", "68462-356-05", "72578-173-01", "72578-174-01", "68462-721-30", "68462-721-01", "68462-721-05", "68462-721-10", "68462-722-30", "68462-722-01", "68462-722-05", "62135-556-47", "62135-556-51", "62135-556-24", "27241-272-01", "27241-273-01", "0480-3310-01", "0480-3309-01", "62332-025-30", "62332-025-31", "62332-025-71", "62332-025-91", "62332-026-30", "62332-026-31", "62332-026-71", "68999-556-51", "68999-556-24", "62135-457-90", "69315-226-01", "69315-227-01", "31722-077-01", "31722-078-01", "69452-267-20", "27808-033-01", "64380-243-01", "64380-244-01", "82638-105-02", "82638-106-02", "23155-742-01", "23155-742-05", "23155-741-01", "23155-741-05", "23155-741-10", "0121-0820-04", "0121-0820-16", "0121-4820-15", "0121-4820-40" ], "nui": [ "N0000175790", "M0023046" ], "pharm_class_epc": [ "Methylxanthine [EPC]" ], "pharm_class_cs": [ "Xanthines [CS]" ], "unii": [ "0I55128JYK", "C137DTR5RG" ] } }, { "drugcharacterization": "2", "medicinalproduct": "NEURONTIN", "openfda": { "application_number": [ "NDA020235", "NDA021129", "NDA020882" ], "brand_name": [ "NEURONTIN" ], "generic_name": [ "GABAPENTIN" ], "manufacturer_name": [ "Parke-Davis Div of Pfizer Inc", "Viatris Specialty LLC" ], "product_ndc": [ "0071-0805", "0071-0803", "0071-0806", "0071-0513", "0071-0401", "0071-2012", "58151-281", "58151-282", "58151-283", "58151-284", "58151-285", "58151-290" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "GABAPENTIN" ], "rxcui": [ "105028", "105029", "105030", "261280", "261281", "283523", "310430", "310431", "310432", "310433", "310434", "351973" ], "spl_id": [ "e730d5df-d47b-4d7f-ae3b-bd449f6b1213", "2d43f32d-2d96-4011-84ac-507c3307dc27" ], "spl_set_id": [ "ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388", "97935fd9-1d4a-43b6-a5d9-de994591187b" ], "package_ndc": [ "0071-0803-24", "0071-0803-40", "0071-0805-24", "0071-0805-40", "0071-0806-24", "0071-0806-40", "0071-0513-24", "0071-0401-24", "0071-2012-23", "0071-2012-44", "0071-2012-47", "58151-281-01", "58151-282-01", "58151-283-01", "58151-284-01", "58151-285-01", "58151-290-35" ], "nui": [ "N0000008486" ], "pharm_class_pe": [ "Decreased Central Nervous System Disorganized Electrical Activity [PE]" ], "unii": [ "6CW7F3G59X" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ATIVAN", "openfda": { "application_number": [ "NDA017794" ], "brand_name": [ "ATIVAN" ], "generic_name": [ "LORAZEPAM" ], "manufacturer_name": [ "Bausch Health US LLC" ], "product_ndc": [ "0187-0063", "0187-0064", "0187-0065" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LORAZEPAM" ], "rxcui": [ "104719", "197900", "197901", "197902", "206821", "206828" ], "spl_id": [ "93bdf2de-1222-44a4-b4d5-2280f9ce58d8" ], "spl_set_id": [ "89057c93-8155-4040-acec-64e877bd2b4c" ], "package_ndc": [ "0187-0063-01", "0187-0063-50", "0187-0063-10", "0187-0064-01", "0187-0064-50", "0187-0064-10", "0187-0065-01", "0187-0065-50", "0187-0065-10" ], "nui": [ "N0000175694", "M0002356" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "unii": [ "O26FZP769L" ] } }, { "drugcharacterization": "2", "medicinalproduct": "METOPROLOL", "openfda": { "application_number": [ "ANDA078950", "ANDA091045", "ANDA202871", "ANDA090317" ], "brand_name": [ "METOPROLOL", "METOPROLOL TARTRATE" ], "generic_name": [ "METOPROLOL TARTRATE", "METOPROLOL", "METOPROLOL TARTRATE INJECTION" ], "manufacturer_name": [ "Baxter Healthcare Corporation", "Fresenius Kabi USA, LLC", "Alembic Pharmaceuticals Inc.", "Oneosource Specialty Pharma Limited", "Alembic Pharmaceuticals Limited" ], "product_ndc": [ "36000-033", "63323-660", "62332-112", "62332-113", "62332-114", "65219-665", "83270-177", "46708-290", "46708-291", "46708-292" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "INTRAVENOUS", "ORAL" ], "substance_name": [ "METOPROLOL TARTRATE" ], "rxcui": [ "866508", "866511", "866514", "866924" ], "spl_id": [ "5d975af3-d078-4130-9448-ed77123f1aac", "4066607a-15cb-42ac-999e-5254907dda5a", "c7738f42-299e-4bea-af50-778e069352f0", "ccb1a15e-c943-4042-ae46-550bdabfc96b", "571d8a14-0118-d00c-e063-6394a90a2769", "f31d2aef-f902-4984-803c-5bdb015e9253" ], "spl_set_id": [ "09566368-f91d-43a3-b683-30c844fb125a", "be1c686e-37a5-4a53-945b-68a6ead35134", "24837d82-0f3f-4482-9af0-31e5f675c30f", "ccb1a15e-c943-4042-ae46-550bdabfc96b", "05946833-9d66-4832-a0d8-b91b1ff01b8b", "cb76a73f-549a-4170-b96a-f93ed7e09464" ], "package_ndc": [ "36000-033-10", "63323-660-01", "63323-660-05", "62332-112-30", "62332-112-31", "62332-112-91", "62332-113-30", "62332-113-31", "62332-113-91", "62332-114-30", "62332-114-31", "62332-114-91", "65219-665-01", "65219-665-05", "83270-177-01", "83270-177-10", "46708-290-30", "46708-290-31", "46708-290-91", "46708-290-10", "46708-290-71", "46708-291-30", "46708-291-31", "46708-291-91", "46708-291-10", "46708-292-30", "46708-292-31", "46708-292-91", "46708-292-10" ], "unii": [ "W5S57Y3A5L" ] } }, { "drugcharacterization": "2", "medicinalproduct": "NEBULIZER" }, { "drugcharacterization": "2", "medicinalproduct": "PRO-AIR" }, { "drugcharacterization": "2", "medicinalproduct": "GLUCAGON", "drugdosageform": "INJECTION", "actiondrug": "5", "openfda": { "application_number": [ "ANDA208086", "ANDA218813", "ANDA214457", "NDA210134", "NDA201849", "ANDA204468" ], "brand_name": [ "GLUCAGON", "BAQSIMI", "GLUCAGON 1555" ], "generic_name": [ "GLUCAGON" ], "manufacturer_name": [ "Amphastar Pharmaceuticals, Inc.", "Cipla USA Inc.", "Lupin Pharmaceuticals, Inc.", "Fresenius Kabi USA, LLC", "Mylan Pharmaceuticals Inc.", "Professional Complementary Health Formulas" ], "product_ndc": [ "0548-5850", "69097-027", "70748-311", "0548-8351", "0548-8352", "63323-594", "63323-596", "63323-582", "0378-8067", "63083-1555", "63323-593" ], "product_type": [ "HUMAN PRESCRIPTION DRUG", "HUMAN OTC DRUG" ], "rxcui": [ "310497", "2180666", "2180671" ], "spl_id": [ "00dea931-5151-4d98-99c4-5aab553a5ad3", "2a2928e9-9131-4fd1-80ac-2d5d44208060", "8acd9382-8718-476e-a625-799607cf84d3", "8d3aa4dd-737c-49b4-af0d-fe95e3bee54d", "9e17207f-b348-4be8-8416-2f0aa1392390", "3d6add4a-5d95-4e63-9761-7e97a92137ba", "e1d65360-2785-4308-8a64-5c2c9e812868", "7d4969d6-8bf1-48cd-89ef-8288937f76b3", "eb37fc8a-a264-4ce9-a130-466e9b5f3a38" ], "spl_set_id": [ "8cc40354-b5ac-45b6-a211-93b44444f2a3", "6e80adb5-f45c-4f92-8dae-ee64217c676f", "3d8c92cf-9263-4126-8a5b-4cd761e31bc1", "f1f5df9b-872f-44e5-a18f-f0b68e7e9254", "8c8acad6-44cc-43aa-966b-027e053be8f5", "c5c431b4-5618-4ff4-954e-4c0fbfed67b6", "15b49500-0aae-4e25-9a1d-709983233cc6", "21d7957c-e682-4e09-b9d3-3ddcca079f69", "e4be1c0e-0fe6-45a0-9229-5cde98434b84" ], "package_ndc": [ "0548-5850-00", "0548-5905-00", "0548-5831-00", "69097-027-50", "69097-028-32", "69097-029-31", "70748-311-01", "70748-309-01", "70748-310-01", "0548-8351-01", "0548-8352-02", "63323-596-08", "63323-596-16", "63323-594-03", "63323-596-06", "63323-185-03", "63323-582-82", "63323-583-13", "63323-185-82", "0378-8067-90", "0378-8065-32", "0378-8066-32", "63083-1555-1", "63323-596-11", "63323-596-13", "63323-593-03", "63323-596-03" ], "route": [ "NASAL", "INTRAMUSCULAR", "INTRAVENOUS", "ORAL" ], "substance_name": [ "GLUCAGON", "GLUCAGON HYDROCHLORIDE" ], "nui": [ "N0000190852", "N0000190853", "N0000009340", "N0000009345", "N0000008636", "N0000008635", "N0000008652" ], "pharm_class_epc": [ "Antihypoglycemic Agent [EPC]", "Gastrointestinal Motility Inhibitor [EPC]" ], "pharm_class_pe": [ "Increased Gluconeogenesis [PE]", "Increased Glycogenolysis [PE]", "Decreased GI Smooth Muscle Tone [PE]", "Decreased GI Motility [PE]", "Decreased Glycolysis [PE]" ], "unii": [ "76LA80IG2G", "1H87NVF4DB" ] } } ] } } ] }